Construction of key question list in the evidence-based guidelines for colorectal cancer screening in China
10.3760/cma.j.issn.0254-6450.2020.02.022
- VernacularTitle:我国结直肠癌筛查循证指南关键问题清单的构建
- Author:
Le GAO
1
;
Shuqing YU
;
Qingxin ZHOU
;
Junling MA
;
Siyan ZHAN
;
Feng SUN
Author Information
1. 北京大学公共卫生学院流行病与卫生统计学系 100191
- Keywords:
Colorectal cancer;
Screening;
Guideline;
Delphi
- From:
Chinese Journal of Epidemiology
2020;41(2):267-272
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish the key question list for the development of evidencebased guideline in China according to the content and limitation of current evidence-based guidelines around the world.Methods First,we introduced the evidence-based guidelines in detail which met the criteria based on World Health Organization guideline development handbook and then formulated the draft list of key questions for the development of evidence-based guidelines.At last,the Delphi method was used to determine the list of key questions in developing evidence-based guidelines of colorectal cancer screening.Results Totally,34 questionnaires were collected,with experts from clinical and epidemiological fields.The average experts' authority coefficient was 0.81,indicating a high degree of authority.The concentration of opinions on all items in the questionnaire was relatively high,with the full score ratio greater than 75％ and the coefficient of variation less than 0.3.The list of key questions on evidence-based guidelines for colorectal cancer screening has been divided into six parts:epidemiological problems,risk classification,screening age,screening tools,implementation and selection of steering group members,which covers the issues that need to be considered in the development of evidence-based colorectal cancer screening guidelines in China.Conclusion The key question list for evidence-based guideline development in our study can be applied to the development of evidence-based guidelines for colorectal cancer screening in the future,as well as the development of evidence-based guidelines for other cancer screening in China.
